The Society of MSK Campaign
The Campaign is The Society's oldest fundraising effort. Each year, MSK's Chief Physician Executive identifies a critical institutional priority for the Campaign to support, and the collective generosity of The Society members and donors provides crucial funding to advance this work.
The 2026–2027 Campaign: Living Treatments. Lasting Hope. Advancing Cellular Immunotherapy at MSK
Help advance a new generation of cancer treatment — one that harnesses living immune cells to recognize and fight disease — and bring the promise of these novel therapies to more people with cancer.
Driving breakthroughs in cancer research and care
MSK has played a defining role in the development of cancer immunotherapy. The Society's 2026–2027 Campaign builds on MSK's legacy by supporting the Center for Cellular Immunotherapy, where researchers are working to discover new ways to empower a patient’s own immune cells to become the treatment — and expand this type of therapy to more people with cancer.
Accelerating progress
A cancer treatment made from living cells presents an extraordinary scientific opportunity. A gift to The Society of MSK’s 2026–2027 Campaign, can help move that opportunity closer to patients by:
- Bringing the success of cellular therapies to solid tumors — cancers that form masses in the body — including cancers of the pancreas, breast, colon, ovary, and lung.
- Transforming treatment for more types of blood cancers, particularly myleoid cancers such as acute myeloid leukemia, which remain difficult to target.
- Developing new approaches for rare cancers affecting children and young adults.
You give hope for more bright futures
Research supported by past Society Campaigns
Since 1946, The Society of MSK has funded critical research projects, ensuring that patients have access to life-changing cancer care. This support has been essential to MSK’s ability to thrive without limits and help people worldwide. Read about past Campaigns below.
Tomorrow’s treatments today
At MSK, pioneering clinical trials transform breakthrough discoveries into life-changing cancer treatments, giving patients access to promising new therapies now, while also advancing care for future generations.
Treating teens and young adults
Colorectal and gastrointestinal cancer diagnoses are rising worldwide for people under 50, and MSK is at the forefront of responding to this global health crisis by advancing leading-edge research and patient care.
New therapies for lymphoma
Home to one of the world’s largest and most innovative research and clinical trial programs focused on lymphoma, MSK is uniquely positioned to uncover new cancer therapies that improve outcomes for people with this disease.
Pancreatic cancer care advances
Pancreatic cancer is often not detected until it has reached a late stage. Through innovative research, MSK scientists are transforming cancer care for people with pancreatic cancer around the world.
Join us in making this year’s Society Campaign a success.
